These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 28359823)

  • 1. Tandem-multimeric F3-gelonin fusion toxins for enhanced anti-cancer activity for prostate cancer treatment.
    Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
    Int J Pharm; 2017 May; 524(1-2):101-110. PubMed ID: 28359823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular tumor targeting of gelonin by fusion with F3 peptide.
    Ham SH; Min KA; Shin MC
    Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy.
    Park T; Min KA; Cheong H; Moon C; Shin MC
    J Drug Target; 2019 Nov; 27(9):950-958. PubMed ID: 30156929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity.
    Shin MC; Min KA; Cheong H; Moon C; Huang Y; He H; Yang VC
    Pharm Res; 2016 Sep; 33(9):2218-2228. PubMed ID: 27251414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity.
    Shin MC; Zhang J; David AE; Trommer WE; Kwon YM; Min KA; Kim JH; Yang VC
    J Control Release; 2013 Nov; 172(1):169-178. PubMed ID: 23973813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy.
    Ham S; Min KA; Yang JW; Shin MC
    Arch Pharm Res; 2017 Sep; 40(9):1094-1104. PubMed ID: 28900896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy.
    Shin MC; Zhang J; Ah Min K; Lee K; Moon C; Balthasar JP; Yang VC
    J Control Release; 2014 Nov; 194():197-210. PubMed ID: 25204286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hepatoma tumor growth by systemic administration of the phytotoxin gelonin driven by the survivin promoter.
    Wang Z; Zhou X; Li J; Liu X; Chen Z; Shen G; Guan T; Ye N; Wei X; Huang N; Yang L; Wei Y; Li J
    Neoplasma; 2013; 60(5):469-79. PubMed ID: 23790164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.
    Shin MC; Zhao J; Zhang J; Huang Y; He H; Wang M; Min KA; Yang VC
    J Biomed Mater Res A; 2015 Jan; 103(1):409-419. PubMed ID: 24733757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Inhibition of Ovarian Cancer by Gelonin Toxin Gene Delivered by Biodegradable Cationic Heparin-polyethyleneimine Nanogels.
    Bai Y; Gou M; Yi T; Yang L; Liu L; Lin X; Su D; Wei Y; Zhao X
    Int J Med Sci; 2015; 12(5):397-406. PubMed ID: 26005374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncations of gelonin lead to a reduction in its cytotoxicity.
    Li Z; Qu Y; Li H; Yuan J
    Toxicology; 2007 Mar; 231(2-3):129-36. PubMed ID: 17222956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gelonin-containing immunotoxin directed against human breast carcinoma.
    Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
    Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostate tumor growth and bone remodeling by the vascular targeting agent VEGF121/rGel.
    Mohamedali KA; Poblenz AT; Sikes CR; Navone NM; Thorpe PE; Darnay BG; Rosenblum MG
    Cancer Res; 2006 Nov; 66(22):10919-28. PubMed ID: 17108129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.
    Pirie CM; Hackel BJ; Rosenblum MG; Wittrup KD
    J Biol Chem; 2011 Feb; 286(6):4165-72. PubMed ID: 21138845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin.
    Rosenblum MG; Cheung LH; Liu Y; Marks JW
    Cancer Res; 2003 Jul; 63(14):3995-4002. PubMed ID: 12873997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fordin: A novel type I ribosome inactivating protein from Vernicia fordii modulates multiple signaling cascades leading to anti-invasive and pro-apoptotic effects in cancer cells in vitro.
    Lu W; Mao Y; Chen X; Ni J; Zhang R; Wang Y; Wang J; Wu L
    Int J Oncol; 2018 Sep; 53(3):1027-1042. PubMed ID: 30015835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of novel, recombinant immunotoxins targeting the Her2/neu oncogene product: in vitro and in vivo studies.
    Cao Y; Marks JD; Marks JW; Cheung LH; Kim S; Rosenblum MG
    Cancer Res; 2009 Dec; 69(23):8987-95. PubMed ID: 19934334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of Recombinant Gelonin Using an Automated Liquid Chromatography System.
    Berstad MEB; Cheung LH; Weyergang A
    Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32823678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study.
    Shin MC; Zhang J; Min KA; He H; David AE; Huang Y; Yang VC
    Pharm Res; 2015 Aug; 32(8):2690-703. PubMed ID: 25701313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.